Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May 9;97(10):5044-9.
doi: 10.1073/pnas.97.10.5044.

Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide

D L Boger  1 , H Sato, A E Lerner, M P Hedrick, R A Fecik, H Miyauchi, G D Wilkie, B J Austin, M P Patricelli, B F Cravatt
Affiliations

Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide

D L Boger et al. Proc Natl Acad Sci U S A. .

Abstract

The development of exceptionally potent inhibitors of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid), and anandamide (an endogenous ligand for cannabinoid receptors) is detailed. The inhibitors may serve as useful tools to clarify the role of endogenous oleamide and anandamide and may prove to be useful therapeutic agents for the treatment of sleep disorders or pain. The combination of several features-an optimal C12-C8 chain length, pi-unsaturation introduction at the corresponding arachidonoyl Delta(8,9)/Delta(11,12) and oleoyl Delta(9,10) location, and an alpha-keto N4 oxazolopyridine with incorporation of a second weakly basic nitrogen provided FAAH inhibitors with K(i)s that drop below 200 pM and are 10(2)-10(3) times more potent than the corresponding trifluoromethyl ketones.

PubMed Disclaimer

Figures

Figure 1
Figure 1
FAAH substrates.
Scheme 1
Scheme 1
See this image and copyright information in PMC

References

    1. Boger D L, Henriksen S J, Cravatt B F. Curr Pharm Des. 1998;4:303–314. - PubMed
    1. Cravatt B F, Prospero-Garcia O, Siuzdak G, Gilula N B, Henriksen S J, Boger D L, Lerner R A. Science. 1995;268:1506–1509. - PubMed
    1. Cravatt B F, Lerner R A, Boger D L. J Am Chem Soc. 1996;118:580–590.
    1. Lerner R A, Siuzdak G, Prospero-Garcia O, Henriksen S J, Boger D L, Cravatt B F. Proc Natl Acad Sci USA. 1994;91:9505–9508. - PMC - PubMed
    1. Huidobro-Toro J P, Harris R A. Proc Natl Acad Sci USA. 1996;93:8078–8082. - PMC - PubMed

Publication types

MeSH terms